These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2574204)

  • 21. Neuroleptic-induced respiratory dyskinesia.
    Kruk J; Sachdev P; Singh S
    J Neuropsychiatry Clin Neurosci; 1995; 7(2):223-9. PubMed ID: 7626967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality.
    Waddington JL; Youssef HA; Dolphin C; Kinsella A
    Arch Gen Psychiatry; 1987 Oct; 44(10):907-12. PubMed ID: 2889438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tardive dyskinesia in bipolar affective disorder: relationship to lithium therapy.
    Dinan TG; Kohen D
    Br J Psychiatry; 1989 Jul; 155():55-7. PubMed ID: 2575003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors related to the severity of tardive dyskinesia.
    Wade JB; Hart RP; Dougherty LM
    Brain Cogn; 1993 Sep; 23(1):71-80. PubMed ID: 8105823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
    Kane JM
    J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involuntary orofacial movements in hospitalised patients with mental handicap or epilepsy: relationship to developmental/intellectual deficit and presence or absence of long-term exposure to neuroleptics.
    Youssef HA; Waddington JL
    J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):863-5. PubMed ID: 2900294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postural stability, tardive dyskinesia and developmental disability.
    Ko YG; Van Emmerik RE; Sprague RL; Newell KM
    J Intellect Disabil Res; 1992 Aug; 36 ( Pt 4)():309-23. PubMed ID: 1356038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive dysfunction in schizophrenia: organic vulnerability factor or state marker for tardive dyskinesia?
    Waddington JL; O'Callaghan E; Larkin C; Kinsella A
    Brain Cogn; 1993 Sep; 23(1):56-70. PubMed ID: 8105822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of negative symptoms with tardive dyskinesia in schizophrenic patients.
    Chiu H; Lau J; Lam L; Shum P
    Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tardive dyskinesia presenting as gastrointestinal disorder.
    Goldberg RJ; Morris PL; Lidofsky S
    J Clin Psychiatry; 1990 Jun; 51(6):253-4. PubMed ID: 1971823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Informing patients about tardive dyskinesia: four-year follow up of a trial of patient education.
    Chaplin R; Timehin C
    Aust N Z J Psychiatry; 2002 Feb; 36(1):99-103. PubMed ID: 11929445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal involuntary movements in patients on long-acting neuroleptics.
    Oyewumi LK; Lapierre YD; Gray R; Batth S; Gelfand R
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):719-23. PubMed ID: 6141614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Episodic tardive dyskinesia and parkinsonism in bipolar disorder patients.
    Scappa S; Teverbaugh P; Ananth J
    Can J Psychiatry; 1993 Dec; 38(10):633-4. PubMed ID: 7906192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesia.
    Rapaport A; Sadeh M; Stein D; Levine J; Sirota P; Mosheva T; Stir S; Elitzur A; Reznik I; Geva D; Rabey JM
    Mov Disord; 2000 Mar; 15(2):352-5. PubMed ID: 10752596
    [No Abstract]   [Full Text] [Related]  

  • 35. Tardive dyskinesia in bipolar affective disorder: aging, cognitive dysfunction, course of illness, and exposure to neuroleptics and lithium.
    Waddington JL; Youssef HA
    Am J Psychiatry; 1988 May; 145(5):613-6. PubMed ID: 2895985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements.
    Brown KW; White T
    Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Akathisia variants and tardive dyskinesia.
    Barnes TR; Braude WM
    Arch Gen Psychiatry; 1985 Sep; 42(9):874-8. PubMed ID: 2864031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accelerometric assessment of tardive dyskinesia.
    Tryon WW; Pologe B
    Am J Psychiatry; 1987 Dec; 144(12):1584-7. PubMed ID: 2891307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tardive dyskinesia syndrome in neuroleptic therapy. General considerations and clinical observations on forty cases investigated.
    Chiriţă V; Boişteanu P; Pirozynski T
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(1):53-64. PubMed ID: 2889249
    [No Abstract]   [Full Text] [Related]  

  • 40. Smoking and movement disorders in psychiatric patients.
    Menza MA; Grossman N; Van Horn M; Cody R; Forman N
    Biol Psychiatry; 1991 Jul; 30(2):109-15. PubMed ID: 1680470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.